Search results
Results from the WOW.Com Content Network
Feng Zhang (Chinese: 张锋; pinyin: Zhāng Fēng; born October 22, 1981) is a Chinese–American biochemist.Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology.
Sherlock Biosciences is a biotechnology company based in Cambridge, Massachusetts developing diagnostic tests using CRISPR-Cas13.The company was founded in 2019 [1] by Feng Zhang, Jim Collins, Omar Abudayyeh, and Jonathan Gootenberg of the Broad Institute.
Editas Medicine was originally founded with the name "Gengine, Inc." in September 2013 by Feng Zhang of the Broad Institute, Jennifer Doudna of the University of California, Berkeley, [7] and George Church, David Liu, and J. Keith Joung of Harvard University, with funding from Third Rock Ventures, Polaris Partners and Flagship Ventures; the name was changed to the current "Editas Medicine" two ...
In 2014, Feng Zhang of the Broad Institute of MIT and Harvard and nine others were awarded US patent number 8,697,359 [25] over the use of CRISPR–Cas9 gene editing in eukaryotes. Although Charpentier and Doudna (referred to as CVC) were credited for the conception of CRISPR, the Broad Institute was the first to achieve a "reduction to ...
An NMT H + flux profile of Arabidopsis root across several zones. This example shows strong H + influx closer to the root tip, and slight H + efflux further from the tip.. Non-invasive micro-test technology (NMT) is a scientific research technology used for measuring physiological events of intact biological samples.
Yi Zhang (Chinese: 张毅; pinyin: Zhāng Yì) is a Chinese-American biochemist who specializes in the fields of epigenetics, chromatin, and developmental reprogramming.He is a Fred Rosen Professor of Pediatrics and professor of genetics at Harvard Medical School, [1] a senior investigator of Program in Cellular and Molecular Medicine at Boston Children's Hospital, [2] and an investigator of ...
News outlets noted that though it was unrealistic to expect quick and huge results from the report, it "offered few clear-cut conclusions regarding the start of the pandemic", "failed to audit the Chinese official position at some parts of the report", and was "biased according to critics".
Shuguang Zhang is an American biochemist. He is at the MIT Media Lab's Laboratory for Molecular Architecture. [1] Shuguang Zhang's research focuses on designs of biological molecules, particularly proteins and peptides. He has published over 200 scientific papers, which have cumulatively been cited over 40,300 times with an h-index of 96.